Issue: 2016 > February > review

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia



REVIEW
Dutch/Belgium HOVON CLL working group: S. Kersting, M-D. Levin, M. Chamuleau, S.M.G.J. Daenen, E.C. Dompeling, J.K. Doorduijn, M. van Gelder, M. Hoogendoorn, J.M. Kerst, M. Nijland, M.R. Nijziel, E.F.M. Posthuma, R.A.P. Raymakers, M.R. Schaafsma, M.H. Silbermann, H.M. van der Straaten, J.H. Veelken, J.M.I. Vos, S. Wittebol, M.H.J. van Oers, A.P. Kater
AbstractFull textPDF

Abstract

In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group.